Case Western Reserve University Tuberculosis Research Unit
  Integrating research to combat the global TB epidemic


Sponsor: European and Developing Countries Clinical Trials Partnership (EDCTP)

(Principal Investigator - Harriet Mayanja-Kizza, MBChB, MMed, Uganda)

Type of Study / Description

The evaluation of Mycobacterium tuberculosis specific host cytokine signatures in whole blood culture supernatants as diagnostic biomarkers for active TB infection

Interactions With TBRU

Collaborating investigators/staff, utilizing shared infrastructure.

Overview of EDCTP
EDCTP is a partnership of 14 European Union countries, Switzerland and Norway, and 47 sub-Saharan African countries, which aims to establish a research and development programme for the development of new or improved clinical interventions to combat HIV/AIDS, tuberculosis and malaria through a long-term partnership between Europe and sub-Saharan Africa.  EDCTP will primarily aim to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria, with focus on phase II and III clinical trials in sub-Saharan Africa. The main objectives are:

  • Acceleration of the development of new or improved clinical interventions, in particular drugs, microbicides and vaccines to fight HIV/AIDS, tuberculosis and malaria in sub-Saharan Africa through conducting and supporting clinical trials especially phases II and III
  • Increasing African research capacity to tackle these diseases
  • Supporting and facilitating the integration of the national health research programmes of the European Member States
  • Strengthening of the related research and development capacity in sub-Saharan Africa. This includes fostering an enabling environment for best practice, including capacity development for Good Clinical Practice (GCP), sound ethical review and a strong regulatory framework.

For further information about EDCTP, visit the website: